. | . | . | Mean HIV Incidence in 2020 (Per 100 Person-Years) . | . | |
---|---|---|---|---|---|
CAB LA Users . | Age (Years) . | Size of Risk Group in 2020 . | Constant Coverage Baseline . | Projected Scale-Up Baseline . | Other Key Characteristics . |
1. Adults | 15–49 | 23.8 million | 0.9 | 0.9 | |
2. Men | 15–49 | 12.6 million | 0.7 | 0.6 | |
3. Women | 15–49 | 11.2 million | 1.2 | 1.2 | Includes FSW |
4. High-risk women | 15–49 | 770 000 | 3.1 | 2.9 | Includes FSW |
5. High-risk young women | 15–30 | 550 000 | 3.3 | 3.1 | Includes 15- to 49-year-old FSW |
. | . | . | Mean HIV Incidence in 2020 (Per 100 Person-Years) . | . | |
---|---|---|---|---|---|
CAB LA Users . | Age (Years) . | Size of Risk Group in 2020 . | Constant Coverage Baseline . | Projected Scale-Up Baseline . | Other Key Characteristics . |
1. Adults | 15–49 | 23.8 million | 0.9 | 0.9 | |
2. Men | 15–49 | 12.6 million | 0.7 | 0.6 | |
3. Women | 15–49 | 11.2 million | 1.2 | 1.2 | Includes FSW |
4. High-risk women | 15–49 | 770 000 | 3.1 | 2.9 | Includes FSW |
5. High-risk young women | 15–30 | 550 000 | 3.3 | 3.1 | Includes 15- to 49-year-old FSW |
Abbreviations: CAB LA, long-acting cabotegravir; FSW, female sex workers; HIV, human immunodeficiency virus.
aAll recipients of CAB LA are assumed to be HIV-negative. HIV incidence is lower in the Projected Scale-up baseline because existing prevention interventions are scaled up from 2019.
. | . | . | Mean HIV Incidence in 2020 (Per 100 Person-Years) . | . | |
---|---|---|---|---|---|
CAB LA Users . | Age (Years) . | Size of Risk Group in 2020 . | Constant Coverage Baseline . | Projected Scale-Up Baseline . | Other Key Characteristics . |
1. Adults | 15–49 | 23.8 million | 0.9 | 0.9 | |
2. Men | 15–49 | 12.6 million | 0.7 | 0.6 | |
3. Women | 15–49 | 11.2 million | 1.2 | 1.2 | Includes FSW |
4. High-risk women | 15–49 | 770 000 | 3.1 | 2.9 | Includes FSW |
5. High-risk young women | 15–30 | 550 000 | 3.3 | 3.1 | Includes 15- to 49-year-old FSW |
. | . | . | Mean HIV Incidence in 2020 (Per 100 Person-Years) . | . | |
---|---|---|---|---|---|
CAB LA Users . | Age (Years) . | Size of Risk Group in 2020 . | Constant Coverage Baseline . | Projected Scale-Up Baseline . | Other Key Characteristics . |
1. Adults | 15–49 | 23.8 million | 0.9 | 0.9 | |
2. Men | 15–49 | 12.6 million | 0.7 | 0.6 | |
3. Women | 15–49 | 11.2 million | 1.2 | 1.2 | Includes FSW |
4. High-risk women | 15–49 | 770 000 | 3.1 | 2.9 | Includes FSW |
5. High-risk young women | 15–30 | 550 000 | 3.3 | 3.1 | Includes 15- to 49-year-old FSW |
Abbreviations: CAB LA, long-acting cabotegravir; FSW, female sex workers; HIV, human immunodeficiency virus.
aAll recipients of CAB LA are assumed to be HIV-negative. HIV incidence is lower in the Projected Scale-up baseline because existing prevention interventions are scaled up from 2019.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.